Blue Fin Capital, Inc. Bristol Myers Squibb CO Transaction History
Blue Fin Capital, Inc.
- $620 Million
- Q3 2025
A detailed history of Blue Fin Capital, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 7,139 shares of BMY stock, worth $334,176. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,139
Previous 7,213
1.03%
Holding current value
$334,176
Previous $439,000
26.88%
% of portfolio
0.05%
Previous 0.09%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...